THE ASSOCIATION BETWEEN TREATMENT INTENSITY AND ADHERENCE TO LIPID-LOWERING THERAPIES AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PRIMARY AND SECONDARY CARE: A SWEDISH REGISTRY-BASED STUDY

被引：0
|
作者：
Leosdottir, M. [1 ]
Vilela, Sorio F. [2 ]
Svensson, Eriksson M. [3 ]
Villa, G. [2 ]
Banefelt, J. [4 ]
Lindh, M. [4 ]
Dun, Rieem A. [4 ]
Norhammar, A. [5 ]
机构：
[1] Skane Univ Hosp, Malmo, Sweden
[2] Amgen Europe GmbH, Rotkreuz, ZG, Switzerland
[3] Uppsala Univ, Uppsala, Sweden
[4] Quantify Res, Stockholm, AB, Sweden
[5] Karolinska Inst, Stockholm, Sweden
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CL3
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [21] Lipid-lowering Therapy Prescription Patterns and Predictors of High Intensity Statin Prescriptions in Patients With Diabetes or Atherosclerotic Cardiovascular Disease
    Chamberlain, Alanna M.
    Cohen, Sarah S.
    Killian, Jill M.
    Monda, Keri L.
    Hedgeman, Elizabeth O.
    Weston, Susan A.
    Okerson, Ted
    CIRCULATION, 2017, 135
  • [22] Lipid-lowering therapies for cardiovascular disease prevention and management in primary care PEER umbrella systematic review of systematic reviews
    Dugre, Nicolas
    Lindblad, Adrienne J.
    Perry, Danielle
    Allan, Michael
    Braschi, Emelie
    Falk, Jamie
    Froentjes, Liesbeth
    Garrison, Scott R.
    Kirkwood, Jessica E. M.
    Korownyk, Christina S.
    McCormack, James P.
    Moe, Samantha S.
    Paige, Allison
    Potter, Jen
    Thomas, Betsy S.
    Ton, Joey
    Young, Jennifer
    Weresch, Justin
    Kolber, Michael R.
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (10) : 701 - 711
  • [23] New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease
    Burger, Achim Leo
    Pogran, Edita
    Muthspiel, Marie
    Kaufmann, Christoph Clemens
    Jaeger, Bernhard
    Huber, Kurt
    BIOMEDICINES, 2022, 10 (05)
  • [24] Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy
    Burke, James P.
    Simpson, Ross J., Jr.
    Paoli, Carly J.
    McPheeters, Jeffrey T.
    Gandra, Shravanthi R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (06) : 1470 - 1480
  • [25] Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: A population-based cohort study
    Sundboll, Jens
    Larsen, Anders Peter
    Veres, Katalin
    Adelborg, Kasper
    Sorensen, Henrik Toft
    THROMBOSIS RESEARCH, 2019, 183 : 124 - 130
  • [26] CARDIOVASCULAR RISK PREVALENCE IN HIGH RISK PRIMARY CARE PATIENTS NOT TREATED WITH LIPID-LOWERING TREATMENT IN FRANCE, RESULTS OF AN ONLINE STUDY
    Kownator, S.
    Ferrieres, J.
    Bruckert, E.
    Bonnelye, G.
    Thomas-delecourt, F.
    Delaage, P. H.
    Dallongeville, J.
    VALUE IN HEALTH, 2012, 15 (07) : A345 - A345
  • [27] UNDERUSE OF LIPID-LOWERING THERAPIES IN PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) IN 2021: RESULTS FROM THE FRENCH NATIONWIDE CLAIMS DATABASE
    Wargny, Matthieu
    Goronflot, Thomas
    Duret, Stephanie
    Pouriel, Mathilde
    Bastien, Alexandre
    Prax, Julie
    Leux, Christophe
    Beliard, Sophie
    Costa, Nadege
    Ferrieres, Jean
    Cariou, Bertrand
    ATHEROSCLEROSIS, 2024, 395
  • [28] LDL-C goal achievement and lipid-lowering therapy in patients by atherosclerotic cardiovascular disease subtype: the SANTORINI study
    Catapano, A. L.
    Manu, M. C.
    Burden, A.
    Ray, K. K.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2373 - 2373
  • [29] High Cardiovascular Disease Risk and Low Lipid-Lowering Treatment in Heterozygous Familial Hypercholesterolemia Patients: A French Nationwide Registry
    Ferrieres, J.
    Farnier, M.
    Bruckert, E.
    Vimont, A.
    Beliard, S.
    VALUE IN HEALTH, 2022, 25 (12) : S198 - S198
  • [30] Adherence to lipid-lowering guidelines for secondary prevention and potential reduction in CVD events in Swedish primary care: a cross-sectional study
    Odesjo, Helena
    Bjorck, Staffan
    Franzen, Stefan
    Hjerpe, Per
    Manhem, Karin
    Rosengren, Annika
    Thorn, Jorgen
    Adamsson Eryd, Samuel
    BMJ OPEN, 2020, 10 (10):
12345